colforsin has been researched along with sorafenib in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiba, T; Hara, H; Ishii, J; Kamma, H; Sawa, A; Yamamoto, H | 1 |
| Heo, J; Kim, AR; Kim, S; Lee, M; Lee, SY; Seo, HR; Shum, D; Song, Y | 1 |
2 other study(ies) available for colforsin and sorafenib
| Article | Year |
|---|---|
Effects of sorafenib and an adenylyl cyclase activator on in vitro growth of well-differentiated thyroid cancer cells.
Topics: Adenylyl Cyclases; Cell Differentiation; Cell Proliferation; Colforsin; Cyclic AMP; Humans; MAP Kinase Signaling System; Niacinamide; Phenylurea Compounds; Signal Transduction; Sorafenib; Thyroid Neoplasms; Tumor Cells, Cultured | 2017 |
Identification of hepatic fibrosis inhibitors through morphometry analysis of a hepatic multicellular spheroids model.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Colforsin; Drug Synergism; Epithelial-Mesenchymal Transition; Fibroblasts; Hep G2 Cells; Hepatic Stellate Cells; Human Umbilical Vein Endothelial Cells; Humans; Liver Cirrhosis; Liver Neoplasms; Small Molecule Libraries; Sorafenib; Spheroids, Cellular; Tretinoin; Tumor Microenvironment | 2021 |